Literature DB >> 6776188

Immunoglobulin synthesis by neoplastic B lymphocytes: free light chain synthesis as a marker of B cell differentiation.

A C Hannam-Harris, J Gordon, J L Smith.   

Abstract

Immunoglobulin synthesis has been investigated in 55 cases of B lymphocytic disease. Free light chain was the predominant product of Ig synthesis and the sole secreted Ig product from neoplasms lacking surface Ig or expressing sparse surface IgM as detected by fluorescent-labeled antibody. In contrast, neoplastic cells expressing strong surface IgM or IgG synthesized and secreted balanced amounts of heavy and light chain. Intermediate patterns of synthesis were shown by neoplastic cells expressing IgM with IgD. These patterns of synthesis occurred irrespective of the disease entity and are discussed in relation to models of B cell maturation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776188

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

2.  Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.

Authors:  M Abe; T Goto; M Kosaka; D Wolfenbarger; D T Weiss; A Solomon
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages.

Authors:  J A Edwards; D B Jones; P R Evans; J L Smith
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

4.  Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.

Authors:  Matthew J Maurer; James R Cerhan; Jerry A Katzmann; Brian K Link; Cristine Allmer; Clive S Zent; Timothy G Call; Kari G Rabe; Curtis A Hanson; Neil E Kay; Susan L Slager; Thomas E Witzig; Tait D Shanafelt
Journal:  Blood       Date:  2011-07-15       Impact factor: 22.113

Review 5.  Treatment of lymphoid tumors with anti-idiotype antibodies.

Authors:  G T Stevenson; F K Stevenson
Journal:  Springer Semin Immunopathol       Date:  1983

6.  Free immunoglobulin light chain synthesis by human foetal liver and cord blood lymphocytes.

Authors:  A C Hannam-Harris; J L Smith
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

7.  Patterns of adenosine deaminase, ecto-5'-nucleotidase, poly(A)polymerase and surface light chain expression in chronic lymphocytic leukemias.

Authors:  T Trangas; N Courtis; A Gounaris; S Perez; D Kokkinopoulos; G A Pangalis; C M Tsiapalis
Journal:  Blut       Date:  1989-04

8.  Polycythaemia rubra vera and hairy cell leukaemia in the same patient: studies on the spleen.

Authors:  G J Mufti; T J Hamblin; F K Stevenson; M Fitchett
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

9.  Biochemical characterization of mIgM- variants of the murine B-cell lymphoma, WEHI 279.1.

Authors:  C H Sibley; R Andrews-Wagner
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

10.  Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study.

Authors:  Huei-Ting Tsai; Neil E Caporaso; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Richard B Hayes; Gerald E Marti; Maher Albitar; Paolo Ghia; S Vincent Rajkumar; Ola Landgren
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.